Keyword: Elijah Cummings

The U.S. lost a drug-pricing watchdog last week as Rep. Elijah Cummings died at age 68, and Democrats are naming their wide-ranging bill after him.

Debt-rating firm Moody's revised its Teva outlook from "stable" to "negative" as the company deals with multiple challenges.

Congressional pharma watchdogs are renewing an earlier request for drug-pricing information, saying three companies might've broken federal law.

U.S. Rep. Elijah Cummings is leading an effort to determine if Gilead's largesse is tied to its efforts to protect Truvada's patents.

Gilead's Truvada for PrEP is only getting to about 10% of people who could benefit, according to testimony Thursday.

Two Republican lawmakers advised drugmakers to not participate in a drug pricing probe in a House committee.

A bipartisan push to lower drug prices could threaten the industry's ability to drive earnings growth, some analysts warn.

Vermont lawmakers took it upon themselves to pass a bill allowing drug imports from Canada. The catch? It'll need an OK from the Trump administration.

President Donald Trump's big speech on drug prices is set for Friday, but Democrats talked up their own proposals Thursday.

Even though drug pricing talk in Washington, D.C., has quieted somewhat, a group of lawmakers continue to beat the drum for reform.